β-Adrenergic stimulation does not activate p38 MAP kinase or induce PGC-1α in skeletal muscle

Sang Hyun Kim, Meiko Asaka, Kazuhiko Higashida, Yumiko Takahashi, John O. Holloszy, Dong Ho Han

研究成果: Article査読

9 被引用数 (Scopus)

抄録

There are reports that the β-adrenergic agonist clenbuterol induces a large increase in peroxisome proliferator-activated receptor-γ{phonetic} coactivator-1α (PGC-1α) in skeletal muscle. This has led to the hypothesis that the increases in PGC-1α and mitochondrial biogenesis induced in muscle by endurance exercise are mediated by catecholamines. In the present study, we evaluated this possibility and found that injecting rats with clenbuterol or norepinephrine induced large increases in PGC-1α and mitochondrial proteins in brown adipose tissue but had no effect on PGC-1α expression or mitochondrial biogenesis in skeletal muscle. In brown adipocytes, the increase in PGC-1α expression induced by β-adrenergic stimulation is mediated by activation of p38 mitogenactivated protein kinase (p38 MAPK), which phosphorylates and activates the cAMP response element binding protein (CREB) family member activating transcription factor 2 (ATF2), which binds to a cyclic AMP response element (CRE) in the PGC-1α promoter and mediates the increase in PGC-1α transcription. Phospho-CREB does not have this effect. Our results show that the reason for the lack of effect of β-adrenergic stimulation on PGC-1α expression in muscle is that catecholamines do not activate p38 or increase ATF2 phosphorylation in muscle.

本文言語English
ジャーナルAmerican Journal of Physiology - Endocrinology and Metabolism
304
8
DOI
出版ステータスPublished - 2013 4 15

ASJC Scopus subject areas

  • 生理学
  • 生理学(医学)
  • 内分泌学、糖尿病および代謝内科学

フィンガープリント

「β-Adrenergic stimulation does not activate p38 MAP kinase or induce PGC-1α in skeletal muscle」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル